Celgene Corp (CELG)

CELG (NASDAQ:Drugs)
$99.78
pos +5.02
+5.30%
Today's Range: 95.60 - 100.55 | CELG Avg Daily Volume: 4,453,600
Last Update: 10/23/14 - 11:41 AM EDT
Volume: 4,185,315
YTD Performance: 12.16%
Open: $95.98
Previous Close: $94.76
52 Week Range: $66.85 - $96.85
Oustanding Shares: 799,510,100
Market Cap: 75,929,474,197
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 16 16 16 17
Moderate Buy 1 1 1 0
Hold 2 3 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.26 1.35 1.43 1.38
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 54.90
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
54.90 54.80 28.03
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.35% 17.83% 183.16%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.90 0.79 0.21
Net Income -0.40 0.65 0.18
EPS 2.00 0.84 0.22
Earnings for CELG:
EBITDA 2.35B
Revenue 6.49B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.82 $0.87 $3.20 $4.38
Number of Analysts 4 4 3 4
High Estimate $0.85 $0.91 $3.24 $4.94
Low Estimate $0.79 $0.85 $3.17 $4.09
Prior Year $0.69 $0.67 $2.68 $3.20
Growth Rate (Year over Year) 17.99% 31.20% 19.28% 37.02%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Doug Kass

 | Oct 23, 2014 | 7:36 AM EDT
Where it began.
By

Jim Cramer

 | Oct 21, 2014 | 1:28 PM EDT

Welcome back to the airlines and the biotechs.

By

Timothy Collins

 | Sep 25, 2014 | 9:58 AM EDT

Technical indicators have now swung in the bears' favor.

By

Jim Cramer

 | Sep 24, 2014 | 11:48 AM EDT

This group reminds us of our nation's innovative spirit and fabulous science.

By

Bob Byrne

 | Sep 16, 2014 | 7:30 AM EDT

The iShares Transportation Average (IYT) is one to watch.

By

Carolyn Boroden

 | Sep 14, 2014 | 6:00 PM EDT

Odds are up for an impending upward reversal.

updateCiti Biotech Conf.

Sep 4, 2014 | 7:37 AM EDT

Citi Biotech Conference 

By

Jim Cramer

 | Sep 2, 2014 | 6:53 AM EDT

Yep, the bets for the rest of 2014 are being placed.

By

Timothy Collins

 | Aug 26, 2014 | 11:54 AM EDT
Checking two biotech charts.
By

Jim Cramer

 | Aug 14, 2014 | 12:18 PM EDT

Amgen's gain is pure insanity from a stock picker's point of view.

Market is off to a great start after yesterday's decline. Solid earnings from Caterpillar...
With the SPX trading in 1% moves per day VIX feels priced right around 16. For now the se...
A lot of noise is being made about this morning's headline that Saudi Arabia supplied less...
I would continue to avoid Altisource. I will have a comprehensive review of Ocwen on Monda...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.